logo
logo

Terray Therapeutics raised $120M in a Series B funding round led by Bedford Ridge Capital to enhance its integrated AI platform and progress clinical trials.

Terray Therapeutics raised $120M in a Series B funding round led by Bedford Ridge Capital to enhance its integrated AI platform and progress clinical trials.

10/17/24, 3:35 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgpasadena
Money raised
$120 million
Round Type
series b
Investors
Alexandria Ventures, Digitalis Ventures, Xtx Ventures, Two Sigma Ventures, Madrona Ventures, Goldcrest Capital, Maverick Capital, N Ventures, Bedford Ridge Capital
Terray Therapeutics, a Los Angeles-based biotechnology company, raised $120M in Series B funding. The round was led by Bedford Ridge Capital with participation from multiple investors to advance clinical trials and its AI platform.

Company Info

Company
Terray Therapeutics
Location
pasadena, california, united states
Additional Info
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.

Related People